-
Mashup Score: 42
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated benefit in patients with heart failure, but minimal data exists around the use of these medications in amyloid light-chain cardiomyopathy (AL-CM). We performed a retrospective study assessing the safety and efficacy of SGLT2i in AL-CM.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1
Podcast Episode · Blood Cancer Talks · 03/14/2024 · 47m
Source: podcasts.apple.comCategories: General Medicine News, Hem/OncsTweet-
@dgermain21 Well said David! I think too much careerism is a source of burnout. In this regard, Dr, Tefferi shared some profound wisdom in one of our @BloodCancerTalk episode! https://t.co/1qWVJfRRzr
-
-
Mashup Score: 16Paper: Development of Anti-Amyloid 11-1F4- CAR Phagocytes for Treatment of AL Amyloidosis - 2 month(s) ago
Program: Oral and Poster Abstracts Type: Oral Session: 651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Understanding and Improving TCE and CAR-T Cell Therapies for Plasma Cell Disorders Hematology Disease Topics & Pathways: Research, Fundamental Science, Translational Research Jing Fu, PhD 1, Huihui Ma, PhD, MD 2 *, Shirong Li, PhD 1, Michael Sang Hughes, MD 3, Gavreel Kalantarov, PhD 1 *, Guifen Liu, MS 1 *, Markus Mapara, MD, PhD 2 * and Suzanne Lentzsch, MD, PhD 4 1 Department
Source: ash.confex.comCategories: General Medicine News, Partners & KOLsTweet-
Intriguing pre-clinical data from @SLentzsch lab @columbiacancer on CAR-modified macrophages targeting 11-1F4 on amyloid fibrils➡️Increased amyloid clearance in vitro and in vivo using humanized AL amyloidosis mouse model! #ASH24 https://t.co/3kp04LpGqH
-
-
Mashup Score: 51
Although sudden death (SD) is a recognized complication of cardiac amyloidosis, there is scarce data about its incidence, mechanisms, and predictors. The aim of this study was to describe incidence…
Source: www.tandfonline.comCategories: General Medicine News, Partners & KOLsTweet-
Sudden Death in AL Cardiac Amyloidosis: ~8% at a median f/u of 1.2 years (most in 1st 6 months) Most common event: PEA 80% during sleeping or resting (not with activity) Beta-blocker use associated with ~7x risk on MVA https://t.co/oZx0q6081L https://t.co/SycLazOsQz https://t.co/COKoJ5XLnQ
-
-
Mashup Score: 8Support my Velocity fundraiser and help Columbia solve cancer. - 4 month(s) ago
On October 6, I’ll be participating in Velocity. I’ve committed to raising crucial funds to help solve cancer at Columbia’s Herbert Irving Comprehensive Cancer Center and I can’t do it without you. Will you support me with a donation today?
Source: www.velocityride.orgCategories: General Medicine News, Partners & KOLsTweet-
🚴♂️Join us for @columbiacancer Velocity Ride and help support our #Myeloma and #Amyoidosis research! @SLentzsch @DivayaB @CAMPamyloidosis https://t.co/niLQBYlXO1 https://t.co/r5XBYl1rH5
-
-
Mashup Score: 42
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated benefit in patients with heart failure, but minimal data exists around the use of these medications in amyloid light-chain cardiomyopathy (AL-CM). We performed a retrospective study assessing the safety and efficacy of SGLT2i in AL-CM.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet-
Safety and Efficacy of SGLT2 Inhibitors in AL Amyloidosis @MathewMaurer @CAMPamyloidosis https://t.co/00XBXqzt0Z https://t.co/h994mWj4Z8 https://t.co/pD0v7dszWw
-
-
Mashup Score: 13
The Glasgow prognostic score (GPS) and CAR-HEMATOTOX (CAR-HT) score identify multiple myeloma (MM) patients at high risk for immune-mediated toxicity and early mortality with cellular immunotherapy. …
Source: onlinelibrary.wiley.comCategories: General Medicine News, Partners & KOLsTweet-
RT @MeeraMohanMD: British Journal of Haematology | Wiley Online Library https://t.co/54ZO37zYyz Can baseline GPS (CRP, albumin) and CART H…
-
-
Mashup Score: 10
The Glasgow prognostic score (GPS) and CAR-HEMATOTOX (CAR-HT) score identify multiple myeloma (MM) patients at high risk for immune-mediated toxicity and early mortality with cellular immunotherapy. …
Source: onlinelibrary.wiley.comCategories: General Medicine News, Partners & KOLsTweet-
RT @MeeraMohanMD: British Journal of Haematology | Wiley Online Library https://t.co/54ZO37zYyz Can baseline GPS (CRP, albumin) and CART H…
-
-
Mashup Score: 28MHG India - 5 month(s) ago
Medical HTML Template
Source: mhgindia.comCategories: General Medicine News, Partners & KOLsTweet-
Excited to join the Mumbai Hematology Group (https://t.co/JYQkTLfUcQ) today for a virtual talk on Bispecific Antibodies in the management of #MultipleMyeloma and AL #Amyloidosis! Link for joining: https://t.co/cZjWA0MZTH #mmsm https://t.co/LkpDPDxCvE
-
-
Mashup Score: 34
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated benefit in patients with heart failure, but minimal data exists around the use of these medications in amyloid light-chain cardiomyopathy (AL-CM). We performed a retrospective study assessing the safety and efficacy of SGLT2i in AL-CM.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet-
Safety and Efficacy of SGLT2 Inhibitors in AL Amyloidosis @MathewMaurer @CAMPamyloidosis https://t.co/00XBXqzt0Z https://t.co/h994mWj4Z8 https://t.co/pD0v7dszWw
-
Safety and Efficacy of SGLT2 Inhibitors in AL Amyloidosis @MathewMaurer @CAMPamyloidosis https://t.co/00XBXqzt0Z https://t.co/h994mWj4Z8 https://t.co/pD0v7dszWw